About - OmniSeq
Our global oncology-specific expertise helps advance cancer diagnostics, drugs and devices through the full drug development continuum with speed and efficiency. We’ve designed our oncology team and resources to help you every step of the way—always working to advance patient care. We provide powerful data and advanced technologies to inform preclinical decisions and oncology model selection; design, manage and recruit for clinical trials; leverage appropriate decentralized techniques; generate ongoing real-world evidence; and perform long-term follow-up studies to support the ongoing development of your product. Welcome to your Labcorp Oncology subscription center, where you can update your contact information, the areas that interest you, and about the specialties you work in. Advancements in oncology are just a click away. From innovative technologies and more inclusive clinical trials to improved access to diagnostic testing, discover how we're democratizing cancer care. We have expanded our offerings with the addition of PGDx, a provider of kitted comprehensive liquid biopsy and tissue-based products and services that broaden access on a global scale. We believe healthcare should be determined by a patient’s genetic code, not their zip code.
This company is:
Verified
OmniSeq Offers Differentiating Platform to Clinically Detect Rare Genetic Alterations to Identify Patients Eligible for New, Targeted Therapy for Lung and Thyroid Cancer - OmniSeq
NGS Test Uses RNA-Sequencing to Detect RET Fusions and DNA-Sequencing to Detect RET Mutations BUFFALO, N.Y., June 29, 2020 /PRNewswire/ — OmniSeq®, an innovator in next generation sequencing (NGS) in oncology, today announced the benefits of its OmniSeq Advance® comprehensive genomic and immune profiling assay to detect the presence of rare alterations in the RET […]
Verified
SVP Corporate Strategy and Business Development Archives - OmniSeq
Chris Drescher | Follow Us on Twitter
View all products
Keywords
Industries
Where is OmniSeq located?
The company OmniSeq is located in Buffalo, New York, United States. It's worth noting that the company may has more corporate locations
How many employees does OmniSeq approximately have?
As of the latest available information OmniSeq has around 51-100 employees worldwide.
When was OmniSeq founded?
OmniSeq was founded in 2015
In which industries does OmniSeq mainly work?
The company OmniSeq has it's main focus in the industries of Biotechnology
What is the current company status of OmniSeq?
Based on the founding year and the amount of employees the company OmniSeq seems to be a Medium-Sized Company at the current state. Note that over time that status can change
Oncologica UK
United Kingdom
51-100 Employees
2014
View
Pangaea Oncology
Spain
View
Ashion Analytics
United States
11-50 Employees
2014
View
Ontada
501-1000 Employees
View
TME Breast Care Network
United States
1-10 Employees
2012
View
OncoCDx | Artificial Intelligence for Personalized Medicine
United Kingdom
11-50 Employees
2018
View
NeoGenomics
United States
501-1000 Employees
2002
View
Sysmex Inostics
Germany
51-100 Employees
2008
View
Topics which have been searched by others and may be interesting for you: